Skip to main content
SpringerLink
Log in

Screening for melanoma

  • Chapter
Advances in Cancer Screening

Part of the book series: Cancer Treatment and Research ((CTAR,volume 86))

Abstract

Screening for cutaneous melanoma was reviewed by the International Union Against Cancer in 1990, with the conclusion that the potential for benefit was considerable, but that the effectiveness for screening was still to be demonstrated [1–3]. In this chapter, selected studies published since then will be reviewed, in the context of trends in melanoma, recommendations for screening, current use of screening, data on the performance of the screening test, and requirements for further research. A previous, detailed review of this topic concluded that screening for melanoma had potential but not demonstrated benefit, had substantial costs and potential hazards, and required further assessment, ideally by a randomized trial [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Elwood JM. 1991. Screening and early diagnosis for melanoma in Australia and New Zealand. In Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds.), Cancer Screening. Cambridge: Cambridge University Press, pp. 243–256.

    Google Scholar 

  2. Ellman R. 1991. Screening for melanoma in the U.K. In Miller AB (ed.), Cancer Screening. Geneva: UICC, pp. 257–266.

    Google Scholar 

  3. Koh HK, Geller AC, Miller DR, Lew RA. 1991. Screening for melanoma/skin cancer in the United States. In Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds.), Cancer Screening. Cambridge: International Union Against Cancer, Cambridge University Press, pp. 267–278.

    Google Scholar 

  4. Elwood JM. 1994. Screening for melanoma and options for its evaluation. J Med Screening 1:22–38.

    CAS  Google Scholar 

  5. Elder DE. 1995. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 75:245–256.

    Article  PubMed  CAS  Google Scholar 

  6. Roush GC, McKay L, Holford TR. 1992. A reversal of the long-term increase in deaths attributable to malignant melanoma. Cancer 69:1714–1720.

    Article  PubMed  CAS  Google Scholar 

  7. Scotto J, Pitcher H, Lee JAH. 1991. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer 49:490–497.

    Article  PubMed  CAS  Google Scholar 

  8. Chen Y, Zheng T, Holford TR, Berwick M, Dubrow R. 1994. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 5:341–350.

    Article  PubMed  CAS  Google Scholar 

  9. Elwood JM. 1992. Primary prevention and early diagnosis of melanoma in Canada: some options for development. Chron Dis Can 13:102–110.

    Google Scholar 

  10. MacLennan R, Green AC, McLeod GRC, Martin NG. 1992. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427–1432.

    Article  PubMed  CAS  Google Scholar 

  11. Jones ME, Shugg D, Dwyer T, Young B, Bonett A. 1992. Interstate differences in incidence and mortality from melanoma: a re-examination of the latitudinal gradient. Med J Aust 157:373–378.

    PubMed  CAS  Google Scholar 

  12. Thorn M, Sparen P, Bergstrom R, Adami H. 1992. Trends in mortality rates from malignant melanoma in Sweden 1953–1987 and forecasts up to 2007. Br J Cancer 66:563–567.

    Article  PubMed  CAS  Google Scholar 

  13. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. 1994. Trends in tumour characteristics and survival of malignant melanoma 1960–84: a population-based study in Sweden. Br J Cancer 70:743–748.

    Article  PubMed  CAS  Google Scholar 

  14. Urist MM, Karnell LH. 1994. The National Cancer Data Base. Report on melanoma. Cancer 74:782–788.

    Article  PubMed  CAS  Google Scholar 

  15. Morris J. 1994. Screening for malignant melanoma. J Med Screening 1:2.

    CAS  Google Scholar 

  16. MacKie RM, Hole D. 1992. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 304:1012–1015.

    Article  CAS  Google Scholar 

  17. Elwood JM. 1993. Recent developments in melanoma epidemiology, 1993. Melanoma Res 3:149–156.

    Article  PubMed  CAS  Google Scholar 

  18. Burton RC, Armstrong BK. 1994. Recent incidence trends imply a non-metastasizing form of invasive melanoma. Melanoma Res 4:107–113.

    Article  PubMed  CAS  Google Scholar 

  19. Burton RC, Coates MS, Hersey P, et al. 1995. An analysis of a melanoma epidemic. Int J Cancer 55:765–770.

    Article  Google Scholar 

  20. Brown L, Palmer PH. 1991. Melanoma incidence in Tauranga 1980–9. N Z Med J 908:109–111.

    Google Scholar 

  21. Elwood JM, Glasgow H. 1993. The Prevention and Early Detection of Melanoma in New Zealand. Wellington: Cancer Society of New Zealand and Department of Health, pp. 1–44.

    Google Scholar 

  22. Elwood JM. 1990. Screening programmes in disease control. In McNeil JJ, King RWF, Jennings GL, Powles JW (eds.), A Textbook of Preventive Medicine. Melbourne: Edward Arnold, pp. 23–44.

    Google Scholar 

  23. American Cancer Society. 1991. Guidelines for the cancer-related checkup: recommendations and rationale. Atlanta: American Cancer Society.

    Google Scholar 

  24. American Academy of Dermatology Committee on Guidelines of Care. 1992. Guidelines of care for nevi 1 (nevocellular nevi and seborrheic keratoses). J Am Acad Dermatol 26:629–631.

    Article  Google Scholar 

  25. Friedman RJ, Rigel DS, Kopf AW. 1985. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 35:130–151.

    Article  PubMed  CAS  Google Scholar 

  26. Canadian Task Force on the Periodic Health Examination. 1984. The periodic health examination: 2. 1984 update. Can Med Assoc J 130:1278–1285.

    Google Scholar 

  27. U.S. Preventive Services Task Force. 1989. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore: Williams & Wilkins.

    Google Scholar 

  28. Marks R. 1991. Screening for melanoma (letter). Med J Aust 154:707.

    PubMed  CAS  Google Scholar 

  29. International Union Against Cancer (UICC). 1992. Melanoma Control Manual. Geneva: UICC.

    Google Scholar 

  30. Kramer BS. 1995. NCI state of the art statements on cancer screening: screening for skin cancer. In Greenwald P, Kramer BS, Weed DL (eds.), Cancer Prevention and Control. New York: Marcel Dekker, pp. 746–747.

    Google Scholar 

  31. National Institutes of Health. 1992. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference: Consensus Statement.

    Google Scholar 

  32. Girgis A, Campbell EM, Redman S, Sanson-Fisher RW. 1991. Screening for melanoma: a community survey of prevalence and predictors. Med J Aust 154:338–343.

    PubMed  CAS  Google Scholar 

  33. Queensland Health. 1991. Enhancing the early detection of melanoma in Queensland. Information circular 23:1–7.

    Google Scholar 

  34. Koh HK. 1991. Cutaneous melanoma. N Engl J Med 325:171–182.

    Article  PubMed  CAS  Google Scholar 

  35. Jelfs PL, Giles G, Shugg D, et al. 1994. Cutaneous malignant melanoma in Australia, 1989. Med J Aust 161:182–187.

    PubMed  CAS  Google Scholar 

  36. Koh HK, Caruso A, Gage I, et al. 1990. Evaluation of melanoma/skin cancer screening in Massachusetts. Cancer 65:375–379.

    Article  PubMed  CAS  Google Scholar 

  37. Rampen FHJ, van Huystee BEWL, Kiemeney LALM. 1991. Melanoma/skin cancer screening clinics: experiences in the Netherlands. J Am Acad Dermatol 25:776–777.

    Article  PubMed  CAS  Google Scholar 

  38. Brandberg Y, Bolund C, Micheleson H, et al. 1993. Psychological reactions in public melanoma screening. Eur J Cancer 29:860–863.

    Article  Google Scholar 

  39. Brandberg Y, Bergenmar M, Bolund C, Månsson-Brahme E, Ringborg U, Sjxdén P. 1992. Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma. Eur J Cancer 28A:1334–1338.

    Article  PubMed  CAS  Google Scholar 

  40. Koh HK, Lew RA, Prout MN. 1989. Screening for melanoma/skin cancer; theoretic and practical considerations. J Am Acad Dermatol 20:159–172.

    Article  PubMed  CAS  Google Scholar 

  41. Kopf AW, Mintzis M, Bart RS. 1975. Diagnostic accuracy in malignant melanoma. Arch Dermatol 111:1291–1292.

    Article  PubMed  CAS  Google Scholar 

  42. Rigel DS, Friedman RJ, Kopf AW, et al. 1986. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 14:857–860.

    Article  PubMed  CAS  Google Scholar 

  43. Leffell DJ, Berwick M, Bolognia J. 1993. The effect of pre-education on patient compliance with full-body examination in a public skin cancer screening. J Dermatol Surg Oncol 19:660–663.

    PubMed  CAS  Google Scholar 

  44. Fitzpatrick TB, Rhodes AR, Sober AJ, Mihm CM Jr. 1988. Primary malignant melanoma of the skin: the call for action to identify persons at risk; to discover precursor lesions; to detect early melanomas. In Elwood JM (ed.), Naevi and Melanoma: Incidence, Interrelationships and Implications; Pigment Cell no. 9. Karger: Basel, pp. 110–117.

    Google Scholar 

  45. MacKie RM. 1990. Clinical recognition of early invasive malignant melanoma: looking for changes in size, shape, and colour is successful. Br Med J 301:1005–1006.

    Article  CAS  Google Scholar 

  46. Rhodes AR. 1995. Public education and cancer of the skin: what do people need to know about melanoma and nonmelanoma skin cancer? Cancer 75:613–636.

    Article  PubMed  CAS  Google Scholar 

  47. Leffell DJ, Chen Y, Berwick M, Bolognia JL. 1993. Interobserver agreement in a community skin cancer screening setting. J Am Acad Dermatol 28:1003–1005.

    Article  PubMed  CAS  Google Scholar 

  48. DeCoste SD, Stern RS. 1993. Diagnosis and treatment of nevomelanocytic lesions of the skin. Arch Dermatol 129:57–62.

    Article  PubMed  CAS  Google Scholar 

  49. Gruber SB, Roush GC, Barnhill RL. 1993. Sensitivity and specificity of self-examination for cutaneous malignant melanoma risk factors. Am J Prev Med 9:50–54.

    PubMed  CAS  Google Scholar 

  50. Lawson DD, Moore DH, Schneider JS, Sagebiel RW. 1994. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician. J Am Acad Dermatol 31:438–444.

    Article  PubMed  CAS  Google Scholar 

  51. Byles JE, Hennrikus D, Sanson-Fisher RW, Hersey P. 1994. Reliability of naevus counts in identifying individuals at high risk of malignant melanoma. Br J Dermatol 130:51–56.

    Article  PubMed  CAS  Google Scholar 

  52. Hennrikus D, Girgis A, Redman S, Sanson-Fisher RW. 1991. A community study of delay in presenting with signs of melanoma to medical practitioners. Arch Dermatol 127:356–361.

    Article  PubMed  CAS  Google Scholar 

  53. MacKie RM. 1993. What are education and screening and diagnosis and prevention of melanoma achieving? Melanoma Research 3:7 (abstract).

    Article  Google Scholar 

  54. Bulliard J, Raymond L, Levi F, et al. 1992. Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique 40:431–438.

    PubMed  CAS  Google Scholar 

  55. Koh HK, Geller AC, Miller DR, Caruso A, Gage I, Lew RA. 1991. Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts. J Am Acad Dermatol 24:271–277.

    Article  PubMed  CAS  Google Scholar 

  56. McGee R, Elwood M, Williams S, Lowry F. 1994. Who comes to skin checks? N Z Med J 107:58–60.

    PubMed  CAS  Google Scholar 

  57. Rampen FHJ, Berretty PJM, van Huystee BEWL, Kiemeney LALM, Nijs CHHM. 1993. Lack of selective attendance of participants at skin cancer/melanoma screening clinics. J Am Acad Dermatol 29:423–427.

    Article  PubMed  CAS  Google Scholar 

  58. Kricker A, English DR, Randell PL, et al. 1990. Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence. Med J Aust 152:399–407.

    PubMed  CAS  Google Scholar 

  59. Reynolds P, Austin DF. 1985. Epidemiologic based screening strategy for malignant melanoma. Prog Clin Biol Res 156:245–254.

    Google Scholar 

  60. Moore D, Martin K, Schneider J. 1993. Aggressive awareness campaign can reduce melanoma mortality. Melanoma Res 3:55 (abstract).

    Article  Google Scholar 

  61. Kraemer KH, Tucker M, Tarone R, Elder DE, Clark WH Jr. 1986. Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B (letter). N Engl J Med 315:1615–1616.

    Article  PubMed  CAS  Google Scholar 

  62. Greene MH, Clark WH, Tucker MA, et al. 1984. Managing the dysplastic naevus syndrome. Lancet i: 166–167.

    Article  Google Scholar 

  63. MacKie RM, McHenry P, Hole D. 1993. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high risk groups. Lancet 341:1618–1620.

    Article  PubMed  CAS  Google Scholar 

  64. Vasen HFA, Berman W, Haeringen A, et al. 1989. The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis — a study of nine families in the Netherlands. Eur J Cancer Clin Oncol 25:337–341.

    Article  PubMed  CAS  Google Scholar 

  65. Elwood JM, Cooke KR, Coombs BD, Cox B, Hand JE, Skegg DCG. 1988. A strategy for the control of malignant melanoma in New Zealand. N Z Med J 101:602–604.

    PubMed  CAS  Google Scholar 

  66. Duray PH, DerSimonian R, Barnhill R, et al. 1992. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol 27:741–749.

    Article  PubMed  CAS  Google Scholar 

  67. Smoller B, Egberg B. 1992. Dysplastic nevi can be diagnosed and graded reproducibility: a longitudinal study. J Am Acad Dermatol 27:741–749.

    Article  Google Scholar 

  68. English DR, Armstrong BK. 1988. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J 296:1285–1288.

    Article  CAS  Google Scholar 

  69. Marrett LD, King WD, Walter SD, From L. 1992. Use of host factors to identify people at high risk for cutaneous malignant melanoma. Can Med Assoc J 147:445–453.

    CAS  Google Scholar 

  70. MacKie RM, Freudenberger T, Aitchison TC. 1989. Personal risk-factor chart for cutaneous melanoma. Lancet 2:487–490.

    Article  PubMed  CAS  Google Scholar 

  71. Goldenhersh MA. 1993. Melanoma screening: critique and proposal. J Am Acad Dermatol 28:642–644.

    Article  PubMed  CAS  Google Scholar 

  72. Koh HK, Geller AC, Miller DR, Lew RA. 1993. Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol 28:645–647.

    Article  PubMed  CAS  Google Scholar 

  73. Berwick M, Dubin N, Roush G, Barnhill R. 1993. Early detection and lethal melanoma in Connecticut: a preliminary analysis. In Gallagher RP, Elwood JM (eds.), Epidemiological Aspects of Cutaneous Malignant Melanoma. Boston: Kluwer, pp. 265–271.

    Google Scholar 

  74. Kenet RO, Kang S, Kenet BJ, et al. 1993. Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Arch Dermatol 129:157–175.

    Article  PubMed  CAS  Google Scholar 

  75. Steiner A, Pehamberger H, Binder M, et al. 1992. Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy. J Am Acad Dermatol 27:697–701.

    Article  PubMed  CAS  Google Scholar 

  76. Green A, Martin N, Pfitzner J, O’Rourke M, Knight N. 1994. Computer image analysis in the diagnosis of melanoma. J Am Acad Dermatol 31:958–964.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Mark Elwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Toronto, Canada

    Anthony B. Miller

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Elwood, J.M. (1996). Screening for melanoma. In: Miller, A.B. (eds) Advances in Cancer Screening. Cancer Treatment and Research, vol 86. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1265-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1265-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8539-7

  • Online ISBN: 978-1-4613-1265-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation